Evaluation of Accuracy of Rapid Tests for Group A Beta Hemolytic Streptococci in Out-patients With Sore Throat

NCT ID: NCT02623985

Last Updated: 2022-10-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

360 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-12-31

Study Completion Date

2017-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate accuracy of rapid tests for group A beta hemolytic streptococci in patients who presented with sore throat at out patient department in Siriraj Hospital.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The patients who presented with sore throat at out patient department less than 5 days and age over 6 years old would be enrolled by the primary physicians and the consent forms will be completed by researcher.

The throat swab would be performed by using Sofia, QuickVue rapid tests compare to the gold standard which is a throat swab culture to evaluate the accuracy of the rapid tests.

The sample size for validation of sensitivity and specificity of rapid tests is 358 patients.

The primary outcome is will be evaluated sensitivity and specificity of both rapid tests.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pharyngitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sofia

Patients who presented with sore throat will be performed throat swab and sent for Sofia which is rapid test.

Group Type EXPERIMENTAL

Sofia

Intervention Type DEVICE

Patients who presented with sore throat will be performed throat swab and sent for Sofia for rapid test.

QuickVue

Patients who presented with sore throat will be performed throat swab and sent for QuickVue which is rapid test.

Group Type EXPERIMENTAL

QuickVue

Intervention Type DEVICE

Patients who presented with sore throat will be performed throat swab and sent for QuickVue for rapid test.

Throat swab culture

Patients who presented with sore throat will be performed throat swab and sent for throat swab culture which is gold standard.

Group Type EXPERIMENTAL

Throat swab culture

Intervention Type DEVICE

Patients who presented with sore throat will be performed throat swab and sent for throat swab culture for gold standard.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Sofia

Patients who presented with sore throat will be performed throat swab and sent for Sofia for rapid test.

Intervention Type DEVICE

QuickVue

Patients who presented with sore throat will be performed throat swab and sent for QuickVue for rapid test.

Intervention Type DEVICE

Throat swab culture

Patients who presented with sore throat will be performed throat swab and sent for throat swab culture for gold standard.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Sofia for rapid test QuickVue for rapid test throat swab culture for gold standard

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who came with sore throat less than 5 days.

Exclusion Criteria

* No
Minimum Eligible Age

7 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mahidol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Adhiratha Boonyasiri

Dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

References

Explore related publications, articles, or registry entries linked to this study.

Plainvert C, Duquesne I, Touak G, Dmytruk N, Poyart C. In vitro evaluation and comparison of 5 rapid antigen detection tests for the diagnosis of beta-hemolytic group A streptococcal pharyngitis. Diagn Microbiol Infect Dis. 2015 Oct;83(2):105-11. doi: 10.1016/j.diagmicrobio.2015.06.012. Epub 2015 Jun 23.

Reference Type BACKGROUND
PMID: 26159722 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

539-2558-EC1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Group A Streptococcus Saliva Study
NCT06473506 ACTIVE_NOT_RECRUITING NA
Gent for Pharyngeal Gonorrhea (GC)
NCT03632109 TERMINATED PHASE2/PHASE3